Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Biospecifics Tech Cp (BSTC)

$49.91 0.07 (0.14%)

16:00 EDT BSTC Stock Quote Delayed 15 Minutes

Volume:

Previous Close $49.91

Market Cap 360.06M

PE Ratio 30.62

EPS 1.63

Volume (Avg. Vol.) 30,900

Day's Range 49.18 - 50.70

52-Week Range 49.00 - 73.31

Dividend & Yield N/A (N/A)

BSTC Stock Predictions, Articles, and Biospecifics Tech Cp News

From the Web

The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings

From Benzinga Oct 15, 2019

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 14.) Natera Inc (NASDAQ...

Biospecifics Technologies is Now Oversold (BSTC)

From Market News Video Oct 11, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Analysts Offer Insights on Healthcare Companies: Capricor Therapeutics (NASDAQ: CAPR), AzurRx BioPharma Inc (NASDAQ: AZRX) and Biospecifics Technologies Corp (NASDAQ: BSTC)

From Analyst Ratings Oct 11, 2019

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Capricor Therapeutics (CAPR – Research Report), AzurRx BioPharma Inc (AZRX – Research Report) and Biospecifics Technologies Corp (BSTC – Research Report) with bullish sentiments. Capricor Therapeutics (CAPR) H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on

BioSpecifics Technologies names J. Kevin Buchi as CEO

From Seeking Alpha Oct 10, 2019

BioSpecifics Technologies (BSTC +0.7%) has appointed Kevin Buchi as Chief Executive Officer of BioSpecifics. He will also serve on the company's board of directors.Mr. Buchi is currently the chairman

Is BioSpecifics Technologies Corp.’s (NASDAQ:BSTC) ROE Of 20% Impressive?

From Simply Wall St Oct 10, 2019

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bstc/biospecifics-technologies/news/is-biospecifics-technologies-corp-s-nasdaqbstc-roe-of-20-impressive/">Read More...</a></div>

Stocks That Hit 52-Week Lows On Tuesday

From Benzinga Oct 8, 2019

Tuesday morning saw 277 companies set new 52-week lows. Areas of Significance: Charles Schwab (NYSE: SCHW) was the largest firm by market cap to set a new 52-week low. Minerco (...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!